Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trialStefan Groeneweg, W. Edward Visser, Klára Roženková et al.|The Lancet Diabetes & Endocrinology|2019Cited by 126
Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort studyStefan Groeneweg, Greta Lyons, Ferdy S. van Geest et al.|The Lancet Diabetes & Endocrinology|2020Cited by 115
Mapping variants in thyroid hormone transporter MCT8 to disease severity by genomic, phenotypic, functional, structural and deep learning integrationStefan Groeneweg, Evelien Gevers, Ferdy S. van Geest et al.|Nature Communications|2025Cited by 6
Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trialStefan Groeneweg, Visser WE, Robin P. Peeters et al.|Yearbook of pediatric endocrinology|2020Cited by 2